Novus International Inc . announced today its intent to acquire the animal nutrition division of Albion Laboratories Inc., a company based in Clearfield, Utah, USA. Terms of the proposed deal were not disclosed.
Products from the acquisition will align with Novus's Mintrex chelated trace mineral products and further expand its mineral technology. When complete, this acquisition will enable Novus to offer its customers and the market an expanded chelated trace mineral product portfolio.
"The intent to acquire Albion's animal division is consistent with the direction Novus has taken to work with industry partners to achieve greater production efficiencies and minimize environmental impact," said Giovanni Gasperoni, executive vice president, Novus International.
"Novus will continue to fully support and invest in its Mintrex chelated trace mineral technology," he continued. "Albion will be viewed as an additional line to support the industry's movement to superior, well-defined and efficacious chelated mineral solutions."
New shelter data casts doubt on whether the pet population and pet ownership are truly growing.
While the pandemic caused unprecedented suffering worldwide in 2020, the disruptions to dogs, cats and other pets adoption numbers may normalize in 2021.